The FDA’s power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from US market


24 January 2023 - Anti-abortion physicians are suing to overturn the FDA’s approval of mifepristone, which dates back more than two decades.

The FDA is squaring off with anti-abortion physicians in an unprecedented legal challenge to its more than two decade old approval of a pill used to terminate early pregnancies.

The Alliance for Hippocratic Medicine asked a federal district court in Dallas late last year to declare the FDA approval unlawful and completely remove the abortion pill from the US market.

Read ABC News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation